MedTrace Logo

A Pooled Analysis of the Data From Two Studies of Ammonium Succinate for Menopausal Symptoms

NCT03043690 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 227

Last updated 2017-10-20

No results posted yet for this study

Summary

This study is a pooled statistical analysis of the data from 2 studies concerning efficacy of ammonium-succinate based dietary supplement. In both studies group 1 took the ammonium-succinate based dietary supplement and the group 2 took placebo.

Conditions

  • Menopause Related Conditions

Interventions

DIETARY_SUPPLEMENT

Ammonium succinate

2 capsules of ammonium succinate-based dietary supplement (one white, 200 mg, and one orange, 200 mg), once a day, in the morning with a meal, for 90 days.

OTHER

Placebo

2 capsules of ammonium succinate-based dietary supplement (one white, 200 mg, and one orange, 200 mg), once a day, in the morning with a meal, for 90 days.

Sponsors & Collaborators

  • I.M. Sechenov First Moscow State Medical University

    lead OTHER

Principal Investigators

  • Irina V Kuznetsova · Sechenov First Moscow Medical University

Eligibility

Min Age
42 Years
Max Age
60 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-02-11
Primary Completion
2017-05-03
Completion
2017-05-30

Countries

  • Russia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03043690 on ClinicalTrials.gov